Participate Today
Save Lives Tomorrow!
Featured Study
MASH Trial
FOMAT is currently enrolling participants for a MASH clinical trial.
Metabolic-associated steatohepatitis (MASH), previously known as non-alcoholic steatohepatitis (NASH), is a silent condition that often remains symptomless until it reaches advanced stages. This disease involves the accumulation of excess fat in the liver, which over time leads to inflammation and liver damage. In its early stages, MASH may go unnoticed, but as it progresses, it can develop into cirrhosis, significantly impairing liver function and increasing the risk of severe complications. Early detection and intervention are crucial to halting the progression of MASH and safeguarding liver health.
Which Clinical Trial Do You Want To Participate In?
Active Studies
Filter Trials By Status
Filter Trials By Location
Filter Trials By Age
Filter Trials by Condition
-
Castroville, Salinas
Chronic Obstructive Pulmonary Disease (COPD)
Join our study on Chronic Obstructive Pulmonary Disease (COPD) to evaluate therapies improving lung function and daily life. We aim to enhance treatment of this progressive respiratory condition.  Criteria & Qualifications: • Aged 40-80, diagnosed with COPD confirmed by spirometry. • Current or former smoker with at least 10 pack-years smoking history. • Must have cardiovascular risk such as hypertension, diabetes, or history of heart disease. Compensation: Contact us for more information
Read more -
Oxnard
Chronic Kidney Disease
Coming Soon! Participate in a Clinical Study on Chronic Kidney Disease, a condition that leads to decreased kidney function over time. We're testing ways to slow progression and improve patient health outcomes.
Read more
Criteria & Qualifications: • Must be diagnosed with Chronic Kidney Disease.
• Aged 18 years or older.
• Willing to undergo periodic evaluations and follow study protocols.
Compensation: Contact us for more information -
Santa Maria
Chronic Heart Failure
This study investigates the progression of Chronic Heart Failure and tests new treatments aimed at improving heart function and quality of life in patients experiencing heart failure symptoms.  Criteria & Qualifications: • More than 18 years old. • Willing to participate in the study. • Currently experiencing symptoms of heart failure.  Compensation: Contact us for more information
Read more -
Oxnard
C. Difficile Infection
Coming Soon! Explore a study on C. Difficile Infection, focusing on its impact on intestinal function and patient well-being. We're testing new treatments to alleviate symptoms and prevent future outbreaks.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Have a confirmed C. difficile diagnosis.
• Willing to participate in a study.
Compensation: Contact us for more information -
Santa Maria
NASH/MASH Study
NASH/MASH is a liver disease with inflammation and damage from fat buildup. If you have NASH/MASH, consider participating in our study to help find new treatments. Criteria & Qualifications: • Must be 18 years or older.
Read more
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation: Contact us for more information. -
Ventura
Asthma Trial
Asthma is a persistent ailment where the airways become swollen and constricted, making breathing difficult. Its symptoms are coughing, wheezing, feeling short of breath, and a tightness in the chest
Read more
Criteria & Qualifications: • Must be 12 years or older.
• Must have an Asthma diagnosis.
• Must be able to provide medical records.
Compensation: Up to $2,000 -
Oxnard
NASH/MASH
NASH/MASH is a silent liver disease that often presents no symptoms until it becomes severe. It begins with excess liver fat and can progress to significant liver damage. Early intervention is crucial to prevent its advancement. -
Oxnard, Salinas
Respiratory Syncytial Virus (RSV)
Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply.
Read more
Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days.
• Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization.
• Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition.
Compensation: Contact us for more information -
Oxnard
Kidney Disease
This study checks a new treatment for severe kidney disease with hormone issues. It has two parts: one with real and fake treatments, and one where all get the real treatment. Doctors will test the results.  Criteria & Qualifications: • Age 18-80. • On hemodialysis 3x a week for 3+ months. Compensation: Contact us for more information
Read more